A single arm, open-label, phase II study of bevacizumab in combination with trastuzumab and capecitabine as first-line treatment of patients with HER2-positive locally recurrent or metastatic breast cancer The primary objective is to evaluate the overall response rate (ORR) in patients with HER2-positive locally advanced or metastatic breast cancer receiving bevacizumab, trastuzumab and capecitabine as ...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Study to Evaluate the Safety and Efficacy of Obinutuzumab, an antibody targeting certain types of immune cells, in Patients with Lupus Nephritis Estudio para evaluar la seguridad y eficacia de obinituzumab, un anticuerpo dirigido a determinado tipo de células inmunes, en pacientes son nefritis lúpica ? To evaluate the efficacy of obinutuzumab compared with placebo in patients with International Society of Nephrology (ISN)/Renal Pathology Society (RPS) Class III or IV Lupus Nephritis (LN) as measur...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Neoadjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Randomized, blinded, controlled study to compare the efficacy of treatment with tocilizumab with or without glucocorticoids in rheumatoid arthritis To compare the impact on disease activity of continued vs. tapered prednisone in RA patients with stable low disease activity (LDA [Disease Activity Score in 28 joints (DAS28) erythrocyte sedimentatio...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A study comparing the clinical benefit and side effects of MPDL3280A to docetaxel in patients with lung cancer who have not benefited from platinum-containing cancer drugs The primary objective of this study is to determine if MPDL3280A treatment results in superior OS compared with docetaxel treatment in patients with locally advanced or metastatic NSCLC who have progr...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A multi-center, double-blind, randomized, placebo-controlled dose-ranging phase 2 study to investigate efficacy, safety, tolerability and pharmacokinetics of RO4389620 in patients with type 2 diabetes mellitus treated with a stable dose of metformin To determine the BID dose(s) of RO4389620 administered in combination with metformin, which when compared to placebo (metformin monotherapy) are efficacious, safe and tolerable in improving glycemic c...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

International study evaluating safety of Obinutuzumab alone or in combination with chemotherapy in patients with Chronic Lymphocytic Leukemia • To evaluate the safety and tolerability of obinutuzumab alone or in combination with chemotherapy

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A study of MDPL3280A in patients with advanced bladder cancer Evaluated the efficacy of MPDL3280A in patients with locally advanced or metastatic urothelial bladder cancer as measured by independent review facility assessed ORR using RECIST v1.1 and investigator...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Phase II, prospective, randomized, double-blind, active-controlled, parallel group, multi-center 'proof of concept' trial in adult patients with community-acquired pneumonia requiring hospitalization without evidence of Legionella To compare the safety, tolerance and efficacy of parenteral RO4908463 to ceftriaxone in patients with community-acquired pneumonia requiring hospitalization without evidence of Legionella.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Study to Compare the Efficacy and Safety of Obinutuzumab + GDC-0199 versus Obinutuzumab + Chlorambucil in Patients with Chronic Lymphocytic Leukemia To determine efficacy by investigator-assessed PFS of a combined regimen of obinutuzumab and Venetoclax compared with GClb in previously untreated patients with CLL who have coexisting medical conditi...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune